Re-evaluation of the natural course of bullous pemphigoid. A prospective study

International Journal of Dermatology

Volumn 38, Issue 12, 1999, Pages 909-913

  Kyriakis, Kyriakos P ^a   Paparizos, Vassilios A ^a   Panteleos, Demetrius N ^a   Tosca, Androniki D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PEMPHIGOID; PREDICTION; RECURRENCE RISK; RISK FACTOR;

AGED; FEMALE; HUMANS; MALE; PEMPHIGOID, BULLOUS; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE;

EID: 0033430981     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1999.00754.x     Document Type: Article

References (28)

1. Korman N. Bullous pemphigoid. J Am Acad Dermatol 1987; 16: 907-924.
2. Anhalt GJ. Pemphigoid. Bullous and cicatricial. Derm Clin 1990; 8: 701-716.
3. Crosby DL, Giudice GJ, Diaz LA. Bullous pemphigoid. In: Demis DJ, ed. Clinical Dermatology, 25th revision. Philadelphia: Lippincot-Raven, 1998: 6-12, 1-13.
4. Adam BA. Bullous diseases in Malaysia. Epidemiology and natural history. Int J Dermatol 1992; 31: 42-45.
5. Kyriakis KP, Panteleos DN, Tosca AD. Sunlight and air temperature affect autoantibody activity and skin involvement of bullous pemphigoid. Int J Dermatol 1996; 35: 498-501.
6. Albergo RP, Gilgor RS. Delayed onset of bullous pemphigoid after PUVA and sunlight treatment for psoriasis. Cutis 1982; 30: 621-624.
7. Kyriakis K, Tosca A, Lehou J, et al. A five year retrospective study on pemphigus and pemphigoid. Australas J Dermatol 1989; 30: 33-36.
8. Costa C, Rilliet A, Nicolet M, et al. Scoring atopic dermatitis: the simpler the better? Acta Derm Venereol 1989; 69: 41-45.
9. Marks R. Early clinical development of tazarotene. Br J Dermatol 1996; 49 (Suppl)L 26-31.
10. Kyriakis KP, Tosca AD. Epidemiologic observations on the natural course of pemphigus vulgaris. Int J Dermatol 1998; 37: 215-219.
11. Armitage P, ed. Statistical Methods in Medical Research. Oxford: Blackwell Scientific Publications, 1980.
12. Beutner EH, Kumar V, Krasny SA, Chorzelski TP. Standardization of antinuclear antibody and other immunofluorescent tests used in immunopathologic studies of the skin. In: Beutner EH, Chorzelski TP, Kumar V, eds. Immunopathology of the Skin, 3rd edn. New York: Wiley, 1987: 41-64.
13. Gammon WR. The immunopathology of bullous pemphigoid antibodies. In: Beutner EH, Chorzelski TP, Kumar V, eds. Immunopathology of the Skin, 3rd edn. New York: Wiley, 1987: 323-336.
14. Sayama K, Yonehara S, Watanabe Y, Miki Y. Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes. J Invest Dermatol 1994; 103: 330-334.
15. Mountz JD, Jianguo W, Cheng J, Zhou T. Autoimmune disease, a problem of defective apoptosis. Arthritis Rheum 1994; 37: 1415-1420.
16. Ahmed AR, Maize JC, Provost TT. Bullous pemphigoid. Clinical and immunologic follow up after successful treatment. Arch Dermatol 1977; 113: 1043-1046.
17. Goldberg DJ, Sabolinski M, Bystryn JC. Regional variations in the expression of bullous pemphigoid antigen and location of lesions in bullous pemphigoid. J Invest Dermatol 1984; 82: 326-328.
18. Hamm G, Wozniak KD. Bullous pemphigoid antigen concentration in normal human skin in relation to body area and age. Arch Dermatol Res 1988; 280: 416-419.
19. Sison-Fonacier L, Bystryn JC. Regional variations in antigenic properties of the skin. A possible cause for disease specific distribution of skin lesions. J Exp Med 1986; 164: 2125-2130.
20. Venning VA, Wojnarowska F. Lack of predictive factors for the clinical course of bullous pemphigoid. J Am Acad Dermatol 1991; 26: 585-589.
21. Venning VA, Frith PA, Bron AJ, et al Mucosal involvement in bullous and cicatricial pemphigoid. A clinical and immunopathological study. Br J Dermatol 1988; 118: 7-15, 22.
22. Venning VA, Whitehead PH, Leigh IM, et al. The clinical expression of bullous pemphigoid is not determined by the specificity of the target antigen. Br J Dermatol 1991; 125: 561-565.
23. Soh H, Hosokawa H, Miyluchi H, et al. Localized pemphigoid shares the same antigen target as bullous pemphigoid. Br J Dermatol 1991; 125: 73-75.
24. Person JR, Rogers RS, Perry HO. Localized pemphigoid. Br J Dermatol 1976; 95: 531-534.
25. Hodge L, Marsden RA, Black MM, et al. Bullous pemphigoid: the frequency of mucosal involvement and concurrent malignancy related to indirect immunofluorescence findings. Br J Dermatol 1981; 105: 65-69.
26. Stone SP, Schroeter A. Bullous pemphigoid and associated malignant neoplasms. Arch Dermatol 1975; 111: 991-994.
27. Lindelof B, Islam N, Eklund G, et al. Pemphigoid and cancer. Arch Dermatol 1990; 126: 66-68.
28. Schaller J, Giese T, Ladusch M, Haustein UF. Interleukin-2 receptor and interleukin-2 production in bullous pemphigoid. Arch Dermatol Res 1990; 282: 223-226.